Loading…
← CockpitCompetitor Analysis › TECX Tectonic Therapeutic IncOpen in the cockpit ↗

Tectonic Therapeutic IncTECXCompetitor analysis, valuation and peers

United States · USD·Health Care›Miscellaneous Commercial Services
Momentum laggard 18
Mkt cap
$420M
US dollars, full cap
Free float
52%
of shares outstanding
$/day
$3.84M
20-day average traded
P/B
1.57×
price to book
ROE
-35.5%
delivered
Implied ROE
16.5%
what the price asks
Next earnings
127 days
25 Mar 2027
Close · USD$21.04
1D+4.8%
1W-4.2%
1M-3.6%
3M-41.6%
6M-27.1%
YTD+0.9%
1Y+14.5%
ATR %6.2%
Beta1.05
52w lowhigh46.8% off high

What Tectonic Therapeutic does

Employees: 60

Tectonic Therapeutic at a glance

Size Tectonic Therapeutic (TECX) is a United States Health Care company (Miscellaneous Commercial Services) with a market value of $420M, the 2803rd largest of 3,085 United States companies the cockpit tracks. Shares closed at $21.04 on 18 Nov 2026.

Performance Over six months the shares fell 27.1%, against +1.8% for the median peer and -2.2% for the United States market (cap-weighted) — 3rd lowest of 8 in its peer set.

Valuation It trades at 1.57× book value against a peer median of 2.24× (3rd cheapest of 8).

Price implies The share price implies a return on equity of about 16.5%; Tectonic Therapeutic delivers -35.5%, so the price asks more than the business earns today.

Short interest Short interest is 11.9% of the free float (30 Oct 2026).

Next results Next results expected around 25 Mar 2027 (exchange calendar; dates can move).

Relative performance

7510012521 May 202621 Aug 202618 Nov 2026Peer median 102TECX 74
Six months, rebased to 100: Tectonic Therapeutic against the median of its 7 peers (local-currency closes).

Tectonic Therapeutic financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$0$0$0$0$0
Revenue growth—————
Gross profit$0-$3.49M-$1.65M-$1.48M-$4.17M
EBITDAn/a-$80.5M-$56.4M-$43.2M-$101M
Net income-$88.1M-$74.2M-$58.0M-$42.8M-$106M
Free cash flown/a-$60.3M-$59.2M-$41.0M-$97.5M
Capital expendituren/a$208,000$156,000$279,000$267,000
Total debtn/a$1.28M$3.30M$85.0M$16.5M

Quarterly statements and history in the cockpit →

Tectonic Therapeutic competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+100%+200%-20%-10%0%+10%EVHOCSEVTANLSBCOABISLNTECX6-month return →1-month return →
Up and to the right = strong over both horizons. Tectonic Therapeutic is the large dot.

Fundamentals: return on equity against price-to-book

-75%-50%-25%0%25%20×40×60×EVHOCSEVTANLSBCOABISLNTECXReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Tectonic Therapeutic is the large dot.

Capital: ROE delivered against the ROE the price implies

-50%0%50%-50%0%50%EVHOCSEVTANLSBCOABISLNTECXROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Tectonic Therapeutic is the large dot.

Tectonic Therapeutic competitors and peer comparison

How Tectonic Therapeutic compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Tectonic Therapeutic against its 7 peers (data as of 18 Nov 2026)
MeasureTECXPeer medianRank in peer set
1-month return-3.6%+0.2%3rd lowest of 8
6-month return-27.1%+1.8%3rd lowest of 8
Return on equity-35.5%-25.1%4th lowest of 8
Price / book1.57×2.24×3rd cheapest of 8
ROE the price implies16.5%13.4%4th most demanding of 8
ROE delivered-35.5%-25.1%4th lowest of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Tectonic Therapeutic TECXUnited States$420M-27%n/a-35%1.57×16.5%-35.5%
Evolent Health EVHUnited States$445M+2%+14%-84%1.19×11.6%-83.6%
Oculis OCSUnited States$456M-74%n/a-49%1.83×9.5%-48.9%
Evotec EVT.DEGermany$532M-46%-5%-25%0.76×8.8%-25.1%
Adlai Nortye Ltd. Sponsored ADR ANLUnited States$610M-23%n/a-20%2.62×27.5%-20.3%
SBC Medical SBCUnited States$645M+94%+7%19%2.24×13.4%19.4%
OmniAb OABIUnited States$741M+97%+91%-17%2.97×18.0%-16.5%
Silence Therapeutics PLC Sponsored ADR SLNUnited States$1.23B+244%-98%-36%5.73×53.1%-35.6%

Questions

Which companies are Tectonic Therapeutic's closest peers?
The cockpit's peer set: Evolent Health (EVH), Oculis (OCS), Evotec (EVT.DE), Adlai Nortye Ltd. Sponsored ADR (ANL), SBC Medical (SBC), OmniAb (OABI), Silence Therapeutics PLC Sponsored ADR (SLN).
Is Tectonic Therapeutic expensive compared with its peers?
On price / book it trades at 1.57× against a peer median of 2.24×, 3rd cheapest of 8 in its peer set. The share price implies a return on equity of about 16.5%; Tectonic Therapeutic delivers -35.5%, so the price asks more than the business earns today.
How has Tectonic Therapeutic stock performed?
Over six months to 18 Nov 2026 the shares returned -27.1% against +1.8% for the median peer; over one year +14.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.